TFX vs WAT: fair value comparison
Teleflex Incorporated and Waters Corporation · Updated 2026-09-06
TFX currently screens as undervalued while WAT screens as fairly valued. Within Healthcare, TFX currently sits closer to the top of our discount ranking.
| TFX | WAT | |
|---|---|---|
| Verdict | Undervalued | Fairly valued |
| Last price | $141.56 | $409.38 |
| 12-month range | $103.36–$140.48 | $299.89–$405.84 |
| Sector rank | #56 of 113 Healthcare | #61 of 113 Healthcare |
| Quality grade | D | D |
| Leverage | Low | Moderate |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Overvalued | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: TFX fair value analysis · WAT fair value analysis